Literature DB >> 4255110

Relation between digitalis binding in vivo and inhibition of sodium, potassium-adenosine triphosphatase in canine kidney.

J C Allen, M Martinez-Maldonado, G Eknoyan, W N Suki, A Schwartz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4255110     DOI： 10.1016/0006-2952(71)90473-4

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  6 in total

1.  Chronic digoxin treatment on canine myocardial Na+, K+ -ATPase.

Authors:  D D Ku; T Akera; T M Brody; L C Weaver
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-12       Impact factor: 3.000

2.  Reduction of the equilibrium binding of cardiac glycosides and related compounds to Na+,K+-ATPase as a possible mechanism for the potassium-induced reversal of their toxicity.

Authors:  T Akera; K Temma; S A Wiest; T M Brody
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-09       Impact factor: 3.000

3.  Saturable adenosine 5'-triphosphate-independent binding of [3H]-ouabain to brain and cardiac tissue in vitro.

Authors:  T Akera; T M Brody; S A Wiest
Journal:  Br J Pharmacol       Date:  1979-03       Impact factor: 8.739

4.  Cardiac glucosides: correlations among Na+ K+-ATPase, sodium pump and contractility in the guinea pig heart.

Authors:  D K Akera; T M Brody; D Ku; C L Pew
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

5.  The effects of ouabain and ethacrynic acid on the intracellular sodium and potassium concentrations in renal medullary slices incubated in cold potassium-free ringer solution and re-incubated at 37 degrees C in the presence of external potassium.

Authors:  R O Law
Journal:  J Physiol       Date:  1976-01       Impact factor: 5.182

6.  Renal sodium-potassium-activated adenosine triphosphatase and sodium reabsorption.

Authors:  M Martinez-Maldonado; J C Allen; C Inagaki; N Tsaparas; A Schwartz
Journal:  J Clin Invest       Date:  1972-10       Impact factor: 14.808
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.